Author: News Room
If you suffered losses exceeding $25,000 investing in Brainstorm securities between August 15, 2022 and September 27, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/BCLI. There is no cost or obligation to you. NEW YORK, Dec. 19, 2023 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Brainstorm Cell Therapeutics Inc. (“Brainstorm” or the “Company”) (NASDAQ: BCLI) and reminds investors of the January 2, 2024 deadline to…
IRVING, Texas, Dec. 19, 2023 (GLOBE NEWSWIRE) — U.S. Oral Surgery Management (USOSM) has partnered with eight new partner practices in seven states: California, Colorado, Oregon, Michigan, Mississippi, South Carolina and Texas. “In 2023, we launched our USOSM Centers of Excellence program, we implemented the USOSM Medical Mission Reimbursement Program, we secured a new $150 million credit expansion, welcomed 21 new associates and we added 25 new partner practices – eight of which, we’re announcing today,” said USOSM President and CEO Richard Hall. “We’re finishing 2023 strong and are positioned for continued growth in 2024 and beyond.” Hall added that…
If you suffered losses exceeding $100,000 investing in DocGo securities between November 8, 2022 and September 17, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/DCGO. There is no cost or obligation to you. NEW YORK, Dec. 19, 2023 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against DocGo Inc. (“DocGo” or the “Company”) (NASDAQ: DCGO) and reminds investors of the December 26, 2023 deadline to seek the…
If you suffered losses exceeding $25,000 investing in Scynexis securities between March 31, 2023 and September 22, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/SCYX. There is no cost or obligation to you. NEW YORK, Dec. 19, 2023 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against SCYNEXIS, Inc. (“Scynexis” or the “Company”) (NASDAQ: SCYX) and reminds investors of the January 8, 2024 deadline to seek the…
HOLLY SPRINGS, N.C., Dec. 19, 2023 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced the onsite Sales Center and model homes are now open at Regency at Holly Springs, an active-adult 55+ community offering two collections of homes with private Regency amenities and social membership to The Club at 12 Oaks in Holly Springs, North Carolina. Home buyers are invited to visit the Sales Center and tour the professionally decorated model homes located at 205 Regency Ridge Road in Holly Springs. Regency at Holly Springs is a premier master-planned community just four…
Christian Kanstrup joined Evaxion as Chief Executive Officer in SeptemberEvaxion has launched its refined strategy with an increased focus on value realization via partnerships based upon the AI-Immunology™ platformSolid progress has already been seen on the refined strategy with two partnerships announced in Q3 and proof-of-principle for Evaxion’s proprietary responder model based upon the AI-Immunology™ platformCash and cash equivalents of $2.6 million on September 30, 2023. On December 18, 2023, Evaxion priced a bridge financing round, expected to raise aggregate proceeds of approximately $5.3 million. This private placement is expected to close on or around December 21, 2023, and will…
NEW YORK, Dec. 19, 2023 (GLOBE NEWSWIRE) — Mark Boidman, Head of the Global Media Group at Solomon Partners, an investment advisory firm, has released his second book, Digital Sign Language: How to Thrive in the New Era of Pro AV and Out of Home Media. The book explores tech transformation in media, including Professional Audio Visual (Pro AV), on-premise and in-store media. It provides a comprehensive guide for the Pro AV hardware and software sectors, as well as marketers, media owners, and investors who want to comprehend and capitalize on the rapidly evolving and highly profitable Pro AV and…
If you suffered losses exceeding $100,000 investing in FMC securities between November 2, 2022 and October 30, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/FMC. There is no cost or obligation to you. NEW YORK, Dec. 19, 2023 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against FMC Corporation (“FMC” or the “Company”) (NYSE: FMC) and reminds investors of the January 8, 2024 deadline to seek the…
Dallas, TX, Dec. 19, 2023 (GLOBE NEWSWIRE) — TCN Worldwide Real Estate Services is delighted to welcome its newest member firm, GLP Values S.A., one of the largest commercial real estate companies in the Greek and European commercial real estate markets. The firm is at the forefront of leading specialized international discussions on timely topics such as distressed investing in non-performing loan markets. GLP Values’ Managing Director, George Litsas, brings a wealth of experience, having served as an executive for financial institutions in London and international real estate companies in Greece and abroad. Recently, Mr. Litsas participated in the “Driving…
If you suffered losses exceeding $100,000 investing in Eagle Pharmaceuticals stock or options between August 8, 2023 and November 28, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/EGRX. There is no cost or obligation to you. NEW YORK, Dec. 19, 2023 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Eagle Pharmaceuticals, Inc. (“Eagle Pharmaceuticals” or the “Company”) (NASDAQ: EGRX) and reminds investors of the February 9,…